Management and prognosis of atrial fibrillation in the diabetic patient

References

• Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306(17):1018-22
   PubMed Web of Science ®Google Scholar
• Friberg J, Buch P, Scharling H, et al. Rising rates of hospital admissions for atrial fibrillation. Epidemiology 2003;14(6):666-72
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart study. JAMA 1994;271(11):840-4
   PubMed Web of Science ®Google Scholar
• Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (Abingdon) 2014;42(12):698-702
   PubMedGoogle Scholar
• Olesen JB, Sørensen R, Hansen ML, et al. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011–2013. Europace 2015;17(2):187-93
   PubMed Web of Science ®Google Scholar
• Kneeland PP, Fang MC. Trends in catheter ablation for atrial fibrillation in the United States. J Hosp Med 2009;4(7):E1-5
   PubMed Web of Science ®Google Scholar
• Aksnes TA, Schmieder RE, Kjeldsen SE, et al. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). Am J Cardiol 2008;101(5):634-8
   PubMed Web of Science ®Google Scholar
• Watanabe H, Tanabe N, Watanabe T, et al. Metabolic Syndrome and Risk of Development of Atrial Fibrillation The Niigata Preventive Medicine Study. Circulation 2008;117(10):1255-60
   PubMed Web of Science ®Google Scholar
• Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care 2009;32(10):1851-6
   PubMed Web of Science ®Google Scholar
• Dublin S, Glazer N, Smith N, et al. Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation. J Gen Intern Med 2010;25(8):853-8
   PubMed Web of Science ®Google Scholar
• Huxley RR, Filion KB, Konety S, et al. Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial Fibrillation. Am J Cardiol 2011;108(1):56-62
   PubMed Web of Science ®Google Scholar
• Lip GYH, Varughese GI. Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links. Int J Cardiol 2005;105(3):319-21
   PubMed Web of Science ®Google Scholar
• Johansen OE, Brustad E, Enger S, et al. Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects. Cardiovasc Diabetol 2008;7:28
   PubMed Web of Science ®Google Scholar
• Tveit A, Abdelnoor M, Enger S, et al. Atrial fibrillation and antithrombotic therapy in a 75-year-old population. Cardiology 2008;109(4):258-62
   PubMed Web of Science ®Google Scholar
• Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up study. Am J Med 1995;98(5):476-84
   PubMed Web of Science ®Google Scholar
• Östgren CJ, Merlo J, Råstam L, et al. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes Obes Metab 2004;6(5):367-74
   PubMed Web of Science ®Google Scholar
• Ruigómez A, Johansson S, Wallander M-A, et al. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 2002;55(4):358-63
   PubMed Web of Science ®Google Scholar
• Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J Intern Med 2002;250(5):382-9
   Web of Science ®Google Scholar
• Jeong JH. Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years. J Korean Med Sci 2005;20(1):26-30
   PubMed Web of Science ®Google Scholar
• Smith J, Platonov P, Hedblad B, et al. Atrial fibrillation in the Malmö diet and cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 2010;25(2):95-102
   PubMed Web of Science ®Google Scholar
• Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol 2008;18(5):209-16
   PubMed Web of Science ®Google Scholar
• Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study. Am J Med 2005;118(5):489-95
   PubMed Web of Science ®Google Scholar
• Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a Risk Factor for Atrial Fibrillation. Circulation 2003;108(24):3006-10
   PubMed Web of Science ®Google Scholar
• Ahlehoff O, Gislason GH, Jørgensen CH, et al. Psoriasis and risk of atrial fibrillation and Ischaemic stroke: a Danish Nationwide Cohort study. Eur Heart J [Internet] 2011; Available from: http://eurheartj.oxfordjournals.org/content/early/2011/08/25/eurheartj.ehr285 [ [Cited 16 May 2012]
   PubMed Web of Science ®Google Scholar
• Kristensen SL, Lindhardsen J, Ahlehoff O, et al. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study. Europace 2014;16(4):477-84
   PubMed Web of Science ®Google Scholar
• Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104(24):2886-91
   PubMed Web of Science ®Google Scholar
• Engelmann MDM, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005;26(20):2083-92
   PubMed Web of Science ®Google Scholar
• Picchi A, Capobianco S, Qiu T, et al. Coronary microvascular dysfunction in diabetes mellitus: a review. World J Cardiol 2010;2(11):377-90
   PubMedGoogle Scholar
• Zhang Q, Liu T, Ng CY, et al. Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies. Cardiovasc Ther 2014;32(5):233-41
   PubMed Web of Science ®Google Scholar
• Goudis CA, Korantzopoulos P, Ntalas IV, et al. Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies. Int J Cardiol 2015;184:617-22
   PubMed Web of Science ®Google Scholar
• Kadappu KK, Boyd A, Eshoo S, et al. Changes in left atrial volume in diabetes mellitus: more than diastolic dysfunction? Eur Heart J Cardiovasc Imaging 2012;13(12):1016-23
   PubMed Web of Science ®Google Scholar
• Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976;53(2):273-9
   PubMed Web of Science ®Google Scholar
• Lee Y-S, Hyun DW, Jung BC, et al. Left atrial volume index as a predictor for occurrence of atrial fibrillation after ablation of typical atrial flutter. J Cardiol 2010;56(3):348-53
   PubMed Web of Science ®Google Scholar
• Otake H, Suzuki H, Honda T, et al. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart. Int Heart J 2009;50(5):627-41
   PubMed Web of Science ®Google Scholar
• Committee TIE. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 2009;32(7):1327-34
   PubMed Web of Science ®Google Scholar
• Huxley RR, Alonso A, Lopez FL, et al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart 2012;98(2):133-8
   PubMed Web of Science ®Google Scholar
• Iguchi Y, Kimura K, Shibazaki K, et al. HbA1c and atrial fibrillation: a cross-sectional study in Japan. Int J Cardiol 2012;156(2):156-9
   PubMed Web of Science ®Google Scholar
• Fatemi O, Yuriditsky E, Tsioufis C, et al. Impact of intensive Glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the action to control cardiovascular risk in diabetes study). Am J Cardiol 2014;114(8):1217-22
   PubMed Web of Science ®Google Scholar
• Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007;69(6):546-54
   PubMed Web of Science ®Google Scholar
• Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154(13):1449-57
   PubMedGoogle Scholar
• Hart RG, Pearce LA, McBride R, et al. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation analysis of 2012 participants in the SPAF I–III clinical trials. Stroke 1999;30(6):1223-9
   PubMed Web of Science ®Google Scholar
• Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2005;112(12):1687-91
   PubMed Web of Science ®Google Scholar
• Stollberger C, Chnupa P, Kronik G, et al. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. Ann Intern Med 1998;128(8):630-8
   PubMed Web of Science ®Google Scholar
• Wang TJ, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham heart study. JAMA 2003;290(8):1049-56
   PubMed Web of Science ®Google Scholar
• Moulton AW, Singer DE, Haas JS. Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. Am J Med 1991;91(2):156-61
   PubMed Web of Science ®Google Scholar
• Saliba W, Barnett-Griness O, Elias M, et al. Glycated hemoglobin and risk of first episode stroke in diabetic patients with atrial fibrillation: a cohort study. Heart Rhythm 2015. [Epub ahead of print]
   Web of Science ®Google Scholar
• Air EL, Kissela BM. Diabetes, the metabolic syndrome, and ischemic stroke epidemiology and possible mechanisms. Diabetes Care 2007;30(12):3131-40
   PubMed Web of Science ®Google Scholar
• Baliga BS, Weinberger J. Diabetes and stroke: part one—risk factors and pathophysiology. Curr Cardiol Rep 2006;8(1):23-8
   PubMedGoogle Scholar
• Pisters R, Lane DA, Marin F, et al. Stroke and thromboembolism in atrial fibrillation. Circ J 2012;76(10):2289-304
   PubMed Web of Science ®Google Scholar
• Camm AJ, Lip GYH, Caterina RD, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation An update of the 2010 ESC Guidelines for the management of atrial fibrillationDeveloped with the special contribution of the European Heart Rhythm Association. Europace 2012;14(10):1385-413
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol 2014;64(21):e1-76
   PubMed Web of Science ®Google Scholar
• Lip GYH, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010;137(2):263-72
   PubMed Web of Science ®Google Scholar
• Gage BF, van Walraven C, Pearce L, et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 2004;110(16):2287-92
   PubMed Web of Science ®Google Scholar
• Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ [Internet] 2011;342: Available from: www.ncbi.nlm.nih.gov/pmc/articles/PMC3031123/ [ [Cited 13 June 2013]
   Google Scholar
• Shireman TI, Mahnken JD, Howard PA, et al. DEvelopment of a contemporary bleeding risk model for elderly warfarin recipients*. Chest 2006;130(5):1390-6
   PubMed Web of Science ®Google Scholar
• Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998;105(2):91-9
   PubMed Web of Science ®Google Scholar
• Fang MC, Go AS, Chang Y, et al. A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol 2011;58(4):395-401
   PubMed Web of Science ®Google Scholar
• Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (has-bled) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey. Chest 2010;138(5):1093-100
   PubMed Web of Science ®Google Scholar
• Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006;151(3):713-19
   PubMed Web of Science ®Google Scholar
• Lip GYH, Andreotti F, Fauchier L, et al. Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. Europace 2011;13(5):723-46
   PubMed Web of Science ®Google Scholar
• Varughese GI, Tomson J, Lip GYH. Type 2 diabetes mellitus: a cardiovascular perspective. Int J Clin Pract 2005;59(7):798-816
   PubMed Web of Science ®Google Scholar
• Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316(23):1429-35
   PubMed Web of Science ®Google Scholar
• Lubitz SA, Benjamin EJ, Ellinor PT. Atrial fibrillation in congestive heart failure. Heart Fail Clin 2010;6(2):187-200
   PubMedGoogle Scholar
• Joshi M, Kotha SR, Malireddy S, et al. Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria. Mol Cell Biochem 2014;386(1-2):233-49
   PubMed Web of Science ®Google Scholar
• Du X, Ninomiya T, de Galan B, et al. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J 2009;30(9):1128-35
   PubMed Web of Science ®Google Scholar
• Liu T, Li G. Thiazolidinediones as novel upstream therapy for atrial fibrillation in diabetic patients: a review of current evidence. Int J Cardiol 2012;156(2):215-16
   PubMed Web of Science ®Google Scholar
• Liu T, Zhao H, Li J, et al. Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits. Cardiovasc Ther 2014;32(4):178-83
   PubMed Web of Science ®Google Scholar
• Chao T-F, Leu H-B, Huang C-C, et al. Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes. Int J Cardiol 2012;156(2):199-202
   PubMed Web of Science ®Google Scholar
• Gu J, Liu X, Wang X, et al. Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus. Europace 2011;13(9):1256-61
   PubMed Web of Science ®Google Scholar
• Chang S-H, Wu L-S, Chiou M-J, et al. Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies. Cardiovasc Diabetol [Internet] 2014;13: Available from: www.ncbi.nlm.nih.gov/pmc/articles/PMC4149273/ [ [Cited 31 March 2015]
   Web of Science ®Google Scholar
• Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365(11):981-92
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361(12):1139-51
   PubMed Web of Science ®Google Scholar
• Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365(10):883-91
   PubMed Web of Science ®Google Scholar
• Ahmad Y, Lip GYH, Apostolakis S. New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation. Expert Rev Cardiovasc Ther 2012;10(12):1471-80
   PubMedGoogle Scholar
• Crijns HJGM, Weijs B, Fairley A-M, et al. Contemporary real life cardioversion of atrial fibrillation: results from the multinational RHYTHM-AF study. Int J Cardiol 2014;172(3):588-94
   PubMed Web of Science ®Google Scholar
• Soran H, Younis N, Currie P, et al. Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation. QJM 2008;101(3):181-7
   PubMed Web of Science ®Google Scholar
• Luong C, Thompson DJS, Bennett M, et al. Right atrial volume is superior to left atrial volume for prediction of atrial fibrillation recurrence after direct current cardioversion. Can J Cardiol 2015;31(1):29-35
   PubMed Web of Science ®Google Scholar
• Dąbrowski R, Opolski G, Włodarczyk P, et al. Demographic and clinical characteristics of patients with atrial fibrillation and cardioversion as planned therapeutic options in the International Registry on Cardioversion of Atrial Fibrillation RHYTHM-AF Polish substudy. Kardiol Pol 2014;72(8):700-6
   PubMed Web of Science ®Google Scholar
• Szulc M, Gurba H, Kuch-Wocial A, et al. Factors related to the early and late success of direct current cardioversion of chronic nonrheumatic atrial fibrillation: an echocardiographic study. Exp Clin Cardiol 2001;6(4):200-5
   PubMedGoogle Scholar
• Guazzi M, Belletti S, Lenatti L, et al. Effects of cardioversion of atrial fibrillation on endothelial function in hypertension or diabetes. Eur J Clin Invest 2007;37(1):26-34
   PubMed Web of Science ®Google Scholar
• Airaksinen KEJ, Grönberg T, Nuotio I, et al. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) Study. J Am Coll Cardiol 2013;62(13):1187-92
   PubMed Web of Science ®Google Scholar
• Tang RB, Dong JZ, Liu XP, et al. Safety and efficacy of catheter ablation of atrial fibrillation in patients with diabetes mellitus–single center experience. J Interv Card Electrophysiol 2006;17(1):41-6
   PubMed Web of Science ®Google Scholar
• Chao T-F, Suenari K, Chang S-L, et al. Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose. Am J Cardiol 2010;106(11):1615-20
   PubMed Web of Science ®Google Scholar
• Lu Z-H, Liu N, Bai R, et al. HbA1c levels as predictors of ablation outcome in type 2 diabetes mellitus and paroxysmal atrial fibrillation. Herz 2014;1-7
   PubMed Web of Science ®Google Scholar
• Lin Y, Li H, Lan X, et al. Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitus. ScientificWorldJournal [Internet] 2013; Available from: www.ncbi.nlm.nih.gov/pmc/articles/PMC3612491/ [ [Cited 26 January 2015]
   Google Scholar
• Kamuhabwa AR, Charles E. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam. Drug Healthc Patient Saf 2014;6:155-65
   PubMedGoogle Scholar
• Maruyama S, Sakura H, Kanno H, et al. Factors associated with glycemic control after an inpatient program. Metabolism 2009;58(6):843-7
   PubMed Web of Science ®Google Scholar
• Camm AJ, Kirchhof P, Lip GYH, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31(19):2369-429
   PubMed Web of Science ®Google Scholar
• Singh DK, Winocour P, Farrington K. Erythropoietic stress and anemia in diabetes mellitus. Nat Rev Endocrinol 2009;5(4):204-10
   PubMed Web of Science ®Google Scholar
• Grodin JL, Tang WHW. Treatment strategies for the prevention of heart failure. Curr Heart Fail Rep [Internet] 2013;10(4): Available from: www.ncbi.nlm.nih.gov/pmc/articles/PMC3823759/ [ [Cited 20 February 2015]
   Google Scholar
• Nesto RW, Bell D, Bonow RO, et al. Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure A Consensus Statement From the American Heart Association and American Diabetes Association. Circulation 2003;108(23):2941-8
   PubMed Web of Science ®Google Scholar
• Forleo GB, Mantica M, De Luca L, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol 2009;20(1):22-8
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384(9945):766-81
   PubMed Web of Science ®Google Scholar
• Karasoy D, Bo Jensen T, Hansen ML, et al. Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study. Europace 2013;15(6):781-6
   PubMed Web of Science ®Google Scholar